Trial Profile
A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 27 Apr 2010 Actual number of patients (5137) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Feb 2010 Planned end date changed from 1 Aug 2010 to 1 Apr 2010 as reported by ClinicalTrials.gov record.